PDF herunterladen
Zentralbl Chir 2016; 141(01): 45-52
DOI: 10.1055/s-0033-1350792
Originalarbeit
Georg Thieme Verlag KG Stuttgart · New York

Aktueller Stand der Antibiotikaprophylaxe in der Adipositas- und metabolischen Chirurgie – Datenanalyse aus der Studie zur Qualitätskontrolle der operativen Therapie der Adipositas in Deutschland

Current Situation of Antibiotic Prophylaxis in Obesity and Metabolic Surgery – Data Analysis from the Study for Quality Assurance in Operative Treatment of Obesity in Germany
C. Stroh
1   Klinik für Allgemein-, Viszeral- und Kinderchirurgie, SRH Wald-Klinikum Gera gGmbH, Deutschland
,
B. Wilhelm
2   Abteilung für Allgemeinchirurgie, Hufeland Klinikum Mühlhausen, Deutschland
,
R. Weiner
3   Chirurgie, KH Sachsenhausen, Frankfurt am Main, Deutschland
,
K. Ludwig
4   Klinik für Chirurgie, Klinikum Südstadt, Rostock, Deutschland
,
F. Benedix
5   Klinik für Allgemein-, Viszeral- und Gefäßchirurgie, Universitätsklinikum Magdeburg A. ö. R., Deutschland
,
C. Knoll
6   Statconsult Magdeburg, Deutschland
,
H. Lippert
5   Klinik für Allgemein-, Viszeral- und Gefäßchirurgie, Universitätsklinikum Magdeburg A. ö. R., Deutschland
,
T. Manger
1   Klinik für Allgemein-, Viszeral- und Kinderchirurgie, SRH Wald-Klinikum Gera gGmbH, Deutschland
,
Kompetenznetz Adipositas
7   Kompetenznetz Adipositas, München, Deutschland
› Institutsangaben
Weitere Informationen

Publikationsverlauf

Publikationsdatum:
13. Dezember 2013 (online)

Auch verfügbar auf
    Lizenzen und Reprints

Zusammenfassung

Hintergrund: Die Studie zur Qualitätssicherung in der operativen Therapie der Adipositas (GBSR) untersucht seit 2005 die aktuelle Situation der Adipositas- und metabolischen Chirurgie in Deutschland. Mithilfe einer Onlinedatenbank werden die Daten prospektiv erfasst und retrospektiv analysiert. Die Datenerfassung erfolgt in Zusammenarbeit mit dem Institut für Qualitätssicherung in der operativen Medizin der Otto-von-Guericke-Universität Magdeburg. Methode: Im Rahmen der prospektiven freiwilligen Datenerfassung werden die Primäroperationen sowie die Re- und Redo-Eingriffe erfasst. Hierbei werden unter anderem Daten zur Antibiotikaprophylaxe dokumentiert und ausgewertet. Ergebnisse: Seit dem Jahr 2005 ist ein stetiger Anstieg der dokumentierten Primäroperationen zu verzeichnen. Die vorliegende Auswertung zur Antibiotikaprophylaxe bezieht sich auf 12 296 Primäreingriffe mit 684 Magenballonimplantationen (BIB), 2950 Magenbandoperationen (Gastric Banding, GB), 5115 Magenbypassoperationen (RYGBP), 120 biliopankreatische Diversionen nach Scopinaro (BPD), 164 Duodenal-Switch-Eingriffe (DS), 3125 Sleeve-Gastrektomien (SG) und 138 weitere Operationen. Insgesamt erfolgte bei 77,3 % der Patienten bei der Primäroperation eine Antibiotikaprophylaxe. Patienten mit Komorbiditäten erhalten signifikant häufiger eine Antibiotikaprophylaxe als Patienten ohne Begleiterkrankungen. Beim Vergleich der Wundinfektionsrate für das GB und die SG findet sich kein signifikanter Unterschied. Fazit: Die Anzahl Adipositas- und metabolisch-chirurgischer Eingriffe hat in Deutschland zugenommen. Zur Notwendigkeit und Dosierung der Antibiotikaprophylaxe existieren in der Literatur nur Empfehlungen geringer Evidenz. Aufgrund der Daten der Qualitätssicherungsstudie für operative Therapie in Deutschland ergibt sich die Empfehlung perioperativer Antibiotikagaben in Abhängigkeit der Komorbiditäten, des BMI und der Operationsdauer.

Abstract

Background: Since January 2005, the situation of metabolic and obesity surgery in Germany has been constantly evaluated by the German Bariatric Surgery Registry (GBSR). Data registration is performed using an internet online database with prospective data collection. All registered data were analysed in cooperation with the Institute of Quality Assurance at the Otto-von-Guericke University Magdeburg. Methods: Data collection includes primary and revision/redo-procedures. A main focus of the current study is the analysis of data regarding the perioperative management, in particular, administration of antibiotics. Results: Since 2005 a significant increase of primary bariatric procedures has been reported. For evaluation of the antibiotic regimen 12 296 primary operations including 684 balloons (BIB), 2950 gastric bandings (GB), 5115 Roux-en-Y-gastric bypasses (RYGBP), 120 Scopinaroʼs biliopancreatic diversions (BPD), 164 duodenal switches (DS), 3125 sleeve gastrectomies (SG) and 138 other procedures were analysed. In total 77.3 % of the patients with primary procedures received perioperative antibiotics. Patients without concomitant comorbidities received antibiotics significantly less often compared to those with comorbidities. Wound infection rates were comparable for patients who underwent either gastric banding or sleeve gastrectomy. Conclusion: Surgery has been accepted step by step as a treatment for morbid obesity and its comorbidities in Germany during the last few years. There is only little experience in the literature regarding antibiotic therapy as well as prophylaxis in bariatric surgery. Based on the results of the current study we recommend rather the selective than the routine use of antibiotics depending on different parameters, e.g., operative time, preoperative BMI and concomitant comorbidities.

Schlüsselwörter

Adipositaschirurgie - perioperative Antibiotikaprophylaxe - Antibiotikatherapie - metabolische Chirurgie - morbide Adipositas - Infektion

Key words

obesity surgery - perioperative antibiotic prophylaxis - antibiotic regimen - antibiotic treatment - metabolic surgery - morbid obesity - infection
 

  • Literatur

  • Weiche I. Reduzierung und Prävention von Übergewicht. Adipositas 2011; 5: 104-107
    PubMedGoogle Scholar
  • Ikramuddin S, Buchwald H. How bariatric and metabolic operations control metabolic syndrome. Br J Surg 2011; 98 : 1339-1341
    PubMedGoogle Scholar
  • Sjöström L, Narbro K, Sjöström CD. et al. Effects of bariatric surgery on mortality in Swedish obese subjects. New Engl J Med 2007; 357: 741-752
    PubMedGoogle Scholar
  • Stroh C, Manger T. Studie zur Qualitätskontrolle der operativen Therapie der Adipositas. Mitt Dtsch Ges Chir 2004; 33: 389-391
    PubMedGoogle Scholar
  • Dindo D, Muller MK, Weber M. et al. Obesity in general elective surgery. Lancet 2003; 361: 2032-2035
    CrossrefPubMedGoogle Scholar
  • Topaloglu S, Avsar FM, Ozel H. et al. Comparison of bariatric and non-bariatric elective operations in morbidly obese patients on the basis of wound infection. Obes Surg 2005; 15: 1271-1276
    CrossrefPubMedGoogle Scholar
  • Runkel N, Colombo-Benkmann M, Hüttl TP. et al. Evidence-based German guidelines for surgery for obesity. Int J Colorectal Dis 2011; 26: 397-404
    PubMedGoogle Scholar
  • Sauerland S, Angrisani L, Belachew M. et al. Evidence-based guidelines of the European Association for Endoscopic Surgery (E.A.E.S.). Surg Endosc 2005; 19: 200-221
    CrossrefPubMedGoogle Scholar
  • Stroh C, Weiner R, Horbach T. et al. [New data on quality assurance in bariatric surgery in Germany]. Zentralbl Chir 2013; 138: 180-188
    Artikel in Thieme ConnectPubMedGoogle Scholar
  • Christou NV, Jarand J, Sylvestre JL. et al. Analysis of the incidence and risk factors for wound infections in open bariatric surgery. Obes Surg 2004; 14: 16-22
    CrossrefPubMedGoogle Scholar
  • Freeman JT, Anderson DJ, Hartwig MG. et al. Surgical site infections following bariatric surgery in community hospitals: a weighty concern?. Obes Surg 2011; 21: 836-840
    CrossrefPubMedGoogle Scholar
  • Ortega J, Cassinello N, Baltasar A. et al. Recommendations for the peri-operative management of bariatric surgery patients: results of a national survey. Cir Esp 2012; 90: 355-362
    CrossrefPubMedGoogle Scholar
  • Paul-Ehrlich-Gesellschaft für Chemotherapie e. V. Perioperative Antibiotika-Prophylaxe. Chemother J 2010; 19: 70-84
    PubMedGoogle Scholar
  • Bittner R, Arregui ME, Bisgaard T. et al. Guidelines for laparoscopic (TAPP) and endoscopic (TEP) treatment of inguinal hernia [International Endohernia Society (IEHS)]. Surg Endosc 2011; 25: 2773-2843
    CrossrefPubMedGoogle Scholar
  • Alexander JW, Rahn R, Goodmann HR. Prevention of surgical site infections by an infusion of topical antibiotic in morbidly obese patients. Surg Infect 2009; 10: 53-57
    CrossrefPubMedGoogle Scholar
  • El-Nashar SA, Diehl CL, Swanson CL. et al. Extended antibiotic prophylaxis for prevention of surgical-site infections in morbidly obese women who undergo combined hysterectomy and medically indicated panniculectomy: a cohort study. Am J Obstet Gynecol 2010; 202: 306.e1-9-306.e1-9
    PubMedGoogle Scholar
  • Chopra T, Zhao JJ, Alangaden G. et al. Preventing surgical site infections after bariatric surgery: value of perioperative antibiotic regimens. Expert Rev Pharmacoecon Outcomes Res 2010; 10: 317-328
    CrossrefPubMedGoogle Scholar
  • Luján JA, Frutos MD, Hernández Q. et al. Laparoscopic versus open gastric bypass in the treatment of morbid obesity: a randomized prospective study. Ann Surg 2004; 239: 433-437
    CrossrefPubMedGoogle Scholar
  • Sánchez-Santos R, Vilarrasa N, Pujol J. et al. Is Roux-en-Y gastric bypass adequate in the super-obese?. Obes Surg 2006; 16: 478-483
    CrossrefPubMedGoogle Scholar
  • Sekhar N, Torquati A, Youssef Y. et al. A comparison of 399 open and 568 laparoscopic gastric bypasses performed during a 4-year period. Surg Endosc 2007; 21: 665-668
    CrossrefPubMedGoogle Scholar
  • Podnos YD, Jimenez JC, Wilson SE. et al. Complications after laparoscopic gastric bypass: a review of 3464 cases. Arch Surg 2003; 138: 957-961
    CrossrefPubMedGoogle Scholar
  • Zelenitsky SA, Silverman RE, Duckworth H. et al. A prospective randomized, double-blind study of high dose versus multiple standard dose gentamicin both in combination with metronidazole for colorectal surgical prophylaxis. J Hosp Infect 2000; 46: 135-140
    CrossrefPubMedGoogle Scholar
  • Zelenitsky SA, Adriano RE, Harding GK. et al. Antibiotic pharmacodynamics in surgical prophylaxis: an association between intraoperative antibiotic concentration and efficacy. Antimicrob Agents Chemother 2002; 46: 3026-3030
    CrossrefPubMedGoogle Scholar
  • Anaya DA, Dellinger EP. The obese surgical patient: a susceptible host for infection. Surg Infect 2006; 7: 473-480
    CrossrefPubMedGoogle Scholar
  • Falagas ME, Karageorgopoulos DE. Adjustment of dosing of antimicrobial agents for bodyweight in adults. Lancet 2010; 375: 248-251
    CrossrefPubMedGoogle Scholar
  • Pai MP, Bearden DT. Antimicrobial dosing considerations in obese adult patients insights from the Society of Infection Diseases Pharmacists. Pharmacotherapy 2007; 27: 1081-1091
    CrossrefPubMedGoogle Scholar
  • Serra Soler G, Galán Ramos N, Martínez-López I. et al. [Study of drug dose calculation for morbidly obese patients]. Farm Hosp 2009; 33: 330-334
    CrossrefPubMedGoogle Scholar
  • Chiba K, Tsuchiya M, Kato J. et al. Cefotiam disposition in markedly obese athlete patients, Japanese sumo wrestlers. Antimicrob Agents Chemother 1989; 33: 1188-1192
    CrossrefPubMedGoogle Scholar
  • Yost RL, Derendorf H. Disposition of cefotaxime and its desacetyl metabolite in morbidly obese male and female subjects. Ther Drug Monit 1986; 8: 189-194
    CrossrefPubMedGoogle Scholar
  • Newman D, Scheetz MH, Adeyemi OA. et al. Serum piperacillin/tazobactam pharmacokinetics in a morbidly obese individual. Ann Pharmacother 2007; 41: 1734-1739
    CrossrefPubMedGoogle Scholar
  • Hollenstein UM, Brunner M, Schmid R. et al. Soft tissue concentrations of ciprofloxacin in obese and lean subjects following weight-adjusted dosing. Int J Obes Relat Metab Disord 2001; 25: 354-358
    PubMedGoogle Scholar
  • Mann HJ, Buchwald H. Cefamandole distribution in serum, adipose tissue, and wound drainage in morbidly obese patients. Drug Intell Clin Pharm 1986; 20: 869-873
    PubMedGoogle Scholar
  • Forse RA, Karam B, MacLean LD. et al. Antibiotic prophylaxis for surgery in morbidly obese patients. Surgery 1989; 106: 750-756
    PubMedGoogle Scholar
  • Edmiston CE, Krepel C, Kelly H. et al. Perioperative antibiotic prophylaxis in the gastric bypass patient: do we achieve therapeutic levels?. Surgery 2004; 136: 738-747
    CrossrefPubMedGoogle Scholar
  • Rich BS, Keel R, Ho VP. et al. Cefepime dosing in the morbidly obese patient population. Obes Surg 2012; 22: 465-471
    CrossrefPubMedGoogle Scholar
  • Chopra T, Marchaim D, Lynch Y. et al. Epidemiology and outcomes associated with surgical site infection following bariatric surgery. Am J Infect Control 2012; 40: 815-819
    PubMedGoogle Scholar
  • Medico CJ, Walsh P. Pharmacotherapy in the ill obese patient. Crit Care Clin 2010; 26: 679-688
    CrossrefPubMedGoogle Scholar
  • Knebel P, Weigand MA, Büchler MW. et al. Evidenzbasierte Antibiotikaprophylaxe in der Allgemein- und Visceralchirurgie. Chirurg 2011; 82: 227-234
    CrossrefPubMedGoogle Scholar